World Summit of Antivirals

Information

About WSA

Organizers & SAB

Program

Document

Call for

Tech Tour

Introduction of Kunming

Registration

Seek Cooperation

Sponsors

Sponsorship Opportunities

Sponsor Now!

Contact Us

	Organization

----------------------------------

	Support Organization

	Partners










more>>

	Gold Sponsor

Track 4: Business Development and Market Trends of Antiviral Therapeutics
-Accelerating Commercially Available Products for the Public

Session 21: Patent Protection and Regulatory Impact for Maximizing Antiviral Product Revenues

Patent Protection is very important Strategy to extend the rights of your product patents, optimize your product lifecycle and yielding a greater ROI through smarter and timely reformulation strategies. With a lack of innovative antiviral drugs emerging from pipelines to replace the loss in revenue resulting from mass patent expiry, research based companies will become increasingly reliant on patent protection strategies for at least their short to medium term growth. Through this workshop you will learn the key principles and successful case studies how to maximize the regulatory benefits for your patented Antiviral Therapeutics, choose the right extension strategies and how to compete effectively post-patent expiry.

This session will cover the following potential topics:

	What is a patent and What can be patented
	Regulatory overview
	Four different patent types and the key to pharmaceutical innovation
	The value of patents and Maximizing regulatory benefits
	Adding value through reformulations and line extensions
	How to Defend patent rights and fight infringement
	Competing post-patent expiry
	The challenge of blockbuster patent expiry
	One company pain is another gain: the multi-billion dollar opportunity for the generics industry
	Threats and opportunities for patent holders
	Protecting your patents - the strategies
	How to Manage Competitive maneuvers of your patents
	How to Application of patent protection strategies to the drug lifecycle
	What can and how to Maximize Regulatory Benefits of your patents
	Supplementary Protection Certificates
	Case Study:Capital Raising for Startup and those at Different Developing Stage with Patented Technologies and Therapeutics
	Case study: Protection in an underserved market
	Case Study: Defending Patent Rights - Fighting Infringement, Licensing, Out-Licensing, Patent Expiry

You can propose your current innovative technologies for antiviral research or drug discovery here

Session 22: Emerging Pharmaceutical Market Trend of the Antiviral

This session will cover the following potential topics:

	Growth opportunities, changing healthcare dynamics & regulatory trends
	Drug Launch Strategies – Market Trends and Regulatory Impacts
	Globalization Strategies for New Antiviral Drugs
	Outsourcing Market for Antiviral Development
	CRO, CMO and OEM for Emerging Antiviral Drugs
	CMO Strategies of Formulated OTC and Prescription New Antiviral Drugs
	Outsourcing Antiviral Productions in Asia or China
	How to expand your business of Antivirals in China
	How to run profitable business of Antiviral Thereapeutics in China with Different Culture Background
	How to manage field force for imported antivirals
	Leading Brands Forecasts
	Antisense
	DNA Polymerase Inhibitors
	RNA Polymerase Inhibitors
	Fusion Inhibitors-Beyond Fuzeon(Roche/Trimeris)
	Inteferons
	Monoclonal Antibodies
	Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
	Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
	NRTIs Combination Franchises
	Nucleotide Reverse Transcriptase Inhibitors (NtRTIs)
	Protease Inhibitors
	Neuraminidase Inhibitors (NIs)
	Future Drugs
	Attachment, Entry and Fusion Inhibitors
	Ongoing pivotal Phase II/III Maraviroc trails
	Safety Profile of Vicriviroc
	Integrase Inhibitors
	Interferons
	Maturation Inhibitors
	Non-Nucleoside Reverse Transcriptase Inhibitors
	Nucleoside Reverse Transcriptase Inhibitors
	Protease Inhibitors
	NS3 Protease Inhibitors
	Polymerase Inhibitors

You can propose your current innovative technologies for antiviral research or drug discovery here

Session 23: Investment on Antiviral R & D and Matching Making Strategies

This session will cover the following potential topics:

	How to find right companies to invest
	How to seek overseas investment for Chinese Pharmaceutical Companies
	How to start up companies for antiviral drug development
	Project and Investment matchmaking roundtable discussion
	Successful case studies of bio-venture at various business phases

You can propose your current innovative technologies for antiviral research or drug discovery here

©2008 All right reserved for BIT Life Sciences
		Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629